These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6322661)

  • 1. Acyclovir--a promising antiviral agent: a review of the preclinical and clinical data in ocular herpes simplex management.
    Koliopoulos J
    Ann Ophthalmol; 1984 Jan; 16(1):19-24. PubMed ID: 6322661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of acyclovir on acute and latent herpes simplex virus infections in the rabbit.
    Trousdale MD; Dunkel EC; Nesburn AB
    Invest Ophthalmol Vis Sci; 1980 Nov; 19(11):1336-41. PubMed ID: 7429768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiviral action and therapeutic effect of acycloguanosine in herpes simplex infection].
    Wang XL
    Zhonghua Yan Ke Za Zhi; 1985 Sep; 21(5):261-4. PubMed ID: 3004845
    [No Abstract]   [Full Text] [Related]  

  • 4. Dendritic keratitis caused by an acyclovir-resistant herpes simplex virus with frameshift mutation.
    Zhang W; Suzuki T; Shiraishi A; Shimamura I; Inoue Y; Ohashi Y
    Cornea; 2007 Jan; 26(1):105-6. PubMed ID: 17198024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil against acute herpes simplex virus keratitis and the establishment of latency: comparison with acyclovir and bromovinyldeoxyuridine.
    Rajcáni J; Reefschläger J
    Acta Virol; 1987 Aug; 31(4):329-39. PubMed ID: 2892382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience.
    Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G
    Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex acyclovir-resistant mutant in experimental keratouveitis.
    Boisjoly HM; Park NH; Pavan-Langston D; De Clercq E
    Arch Ophthalmol; 1983 Nov; 101(11):1782-6. PubMed ID: 6314952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of acyclovir on acute ocular infection induced by drug-resistant strains of HSV-1.
    Trousdale MD; Nesburn AB; Miller CA
    Invest Ophthalmol Vis Sci; 1981 Feb; 20(2):230-5. PubMed ID: 6257622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
    Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
    Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
    Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
    J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.
    Richards DM; Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Nov; 26(5):378-438. PubMed ID: 6315332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined therapy of acyclovir and cyclocytidine against herpes simplex virus].
    Chen ZJ; Liu WG; Song JZ; Zhang Y
    Zhongguo Yao Li Xue Bao; 1988 Jul; 9(4):364-6. PubMed ID: 2461639
    [No Abstract]   [Full Text] [Related]  

  • 13. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C; Bianchi A
    Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment trials of the therapeutic efficacy of the drug "Zovirax" in some recurrent ocular and genital herpetic infections.
    Muţiu A; Sahnazarov N; Crişan I
    Rom J Virol; 1998; 49(1-4):27-42. PubMed ID: 10892424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of three antiviral drugs in mice herpetic keratitis.
    Inoue Y; Ohashi Y; Shimomura Y; Manabe R; Yamada M; Ueda S; Kato S
    Jpn J Ophthalmol; 1989; 33(1):125-31. PubMed ID: 2543857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyclovir.
    Appelboom TM; Flowers FP
    South Med J; 1983 Jul; 76(7):905-9. PubMed ID: 6306847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
    Verdonck LF; Cornelissen JJ; Smit J; Lepoutre J; de Gast GC; Dekker AW; Rozenberg-Arska M
    Bone Marrow Transplant; 1993 Feb; 11(2):177-9. PubMed ID: 8382096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of therapeutic activity of idoxuridine and acyclovir in experimentally-induced herpetic keratitis in rabbits (author's transl)].
    Colin C; Chastel C; Quillien MC; Renard G
    J Fr Ophtalmol; 1981; 4(1):33-43. PubMed ID: 7217623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preventive treatment of herpetic keratitis with acyclovir tablets].
    Colin J; Robinet A; Malet F
    J Fr Ophtalmol; 1993; 16(1):6-9. PubMed ID: 8482804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of antiviral activities of acyclovir in vitro and in vivo.
    Collins P
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():19-27. PubMed ID: 6313598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.